Aardvark Therapeutics, Inc. Balance Sheet
Aardvark Therapeutics, Inc.'s total assets for Q4 2025 were $117.18M, a decrease of -12.05% from the previous quarter. AARD total liabilities were $10.55M for the fiscal quarter, a -2.80% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.